Trial Profile
Comparison of effects of prasugrel and ticagrelor in patients with acute coronary syndrome.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Mar 2015
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary)
- Indications Acute coronary syndromes
- Focus Pharmacodynamics
- 11 Mar 2015 New trial record